Mister Spex Future Growth
Future criteria checks 0/6
Mister Spex is forecast to grow earnings and revenue by 45.9% and 2.6% per annum respectively. EPS is expected to grow by 50.5% per annum. Return on equity is forecast to be -15.6% in 3 years.
Key information
45.9%
Earnings growth rate
50.5%
EPS growth rate
Specialty Retail earnings growth | 38.2% |
Revenue growth rate | 2.6% |
Future return on equity | -15.6% |
Analyst coverage | Low |
Last updated | 15 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 237 | -18 | -1 | 7 | 4 |
12/31/2025 | 226 | -27 | -9 | 1 | 4 |
12/31/2024 | 220 | -50 | -32 | -18 | 4 |
9/30/2024 | 226 | -55 | -21 | -13 | N/A |
6/30/2024 | 229 | -49 | -12 | -3 | N/A |
3/31/2024 | 229 | -49 | 3 | 15 | N/A |
12/31/2023 | 228 | -48 | -9 | 6 | N/A |
9/30/2023 | 226 | -44 | -18 | -1 | N/A |
6/30/2023 | 225 | -44 | -28 | -9 | N/A |
3/31/2023 | 220 | -43 | -48 | -29 | N/A |
12/31/2022 | 217 | -45 | -41 | -21 | N/A |
9/30/2022 | 218 | -32 | -42 | -23 | N/A |
6/30/2022 | 209 | -31 | -49 | -31 | N/A |
3/31/2022 | 204 | -36 | -47 | -29 | N/A |
12/31/2021 | 201 | -32 | -44 | -28 | N/A |
9/30/2021 | 195 | -29 | -28 | -14 | N/A |
6/30/2021 | 190 | -23 | -8 | 5 | N/A |
3/31/2021 | 178 | -11 | -1 | 10 | N/A |
12/31/2020 | 168 | -10 | -15 | -2 | N/A |
12/31/2019 | 143 | -9 | -7 | 1 | N/A |
12/31/2018 | 126 | -11 | -10 | -3 | N/A |
12/31/2017 | 107 | -14 | N/A | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MRX's revenue (2.6% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: MRX's revenue (2.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MRX is forecast to be unprofitable in 3 years.